Peer Review reports
From: Mepolizumab-Induced Posterior Reversible Encephalopathy Syndrome (PRES), a new patient report
| Original Submission | ||
|---|---|---|
| 10 Dec 2020 | Submitted | Original manuscript |
| 3 Jun 2021 | Reviewed | Reviewer Report |
| 2 Jul 2021 | Reviewed | Reviewer Report |
| 14 Nov 2021 | Author responded | Author comments - Vikram V Puram |
| Resubmission - Version 2 | ||
| 14 Nov 2021 | Submitted | Manuscript version 2 |
| 4 Dec 2021 | Author responded | Author comments - Vikram V Puram |
| Resubmission - Version 3 | ||
| 4 Dec 2021 | Submitted | Manuscript version 3 |
| 21 Feb 2022 | Author responded | Author comments - Vikram V Puram |
| Resubmission - Version 4 | ||
| 21 Feb 2022 | Submitted | Manuscript version 4 |
| Publishing | ||
| 23 Feb 2022 | Editorially accepted | |
| 25 Aug 2022 | Article published | 10.1186/s12883-022-02849-1 |
You can find further information about peer review here.